Application
SUCLA2 Antibody (Center) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SUCLA2 antibody detected the SUCLA2 protein (arrow).Application
SUCLA2 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the SUCLA2 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.Application
SUCLA2 Antibody (Center) flow cytometric analysis of HepG2 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | SUCLA2 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SUCLA2; Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial; ATP-specific succinyl-CoA synthetase subunit beta; Renal carcinoma antigen NY-REN-39; Succinyl-CoA synthetase beta-A chain |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHCFC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | SUCLA2 Succinyl-CoA ligase [ADP-forming] subunit beta mitochondrial ATP-specific succinyl-CoA synthetase subunit beta Renal carcinoma antigen NY-REN-39 Succinyl-CoA synthetase beta-A chain |
|---|---|
| Molecular Weight(MW) | 50317 Da |
| Function | Catalyzes the ATP-dependent ligation of succinate and CoA to form succinyl-CoA (By similarity) |
| Tissue Specificity | Widely expressed. Not expressed in liver and lung |
| Cellular Localization | Mitochondrion. |
| Entrez Gene | 8803 |
|---|---|
| Nucleotide Accession | NP_003841.1 |
Application
SUCLA2 Antibody (Center) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SUCLA2 antibody detected the SUCLA2 protein (arrow).
Application
SUCLA2 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the SUCLA2 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.
Application
SUCLA2 Antibody (Center) flow cytometric analysis of HepG2 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
